| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6180941 | Fertility and Sterility | 2015 | 10 Pages |
Abstract
PGS with the use of CCS technology increases clinical and sustained IRs, thus improving embryo selection, particularly in patients with normal ovarian reserve. Results from ongoing RCTs conducted on different patient populations (e.g., decreased ovarian reserve) and different embryo stage biopsy (e.g., PB, day 3) may further clarify the role of this technology.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Elias M. M.D., M.Sc., Jacques M.D., Juan Antonio M.D., Ph.D.,